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ABSTRACT
Goodhart, John Matthew. M.S. The University of Memphis. August 2012.
Design and Validation of a Cyclic Strain Bioreactor to Condition Spatially-Selective
Scaffolds in Dual Strain Regimes. Major Professor: Dr. Joel Bumgardner.
The objective of this study was to design and validate a unique bioreactor design
for applying spatially-selective, linear, cyclic strain to degradable polymeric fabric
scaffolds. Image analysis of polyethylene terephthalate (PET) scaffolds subjected to 3%
mechanical stretch showed that the stretched and unstretched portions of the scaffolds
experienced 2.97±0.13% and 0.02±0.18% strain respectively. NIH-3T3 fibroblast cells
were cultured on PET scaffolds and half of each scaffold was stretched 5% at 0.5 Hz for
one hour per day for 14 days in the bioreactor. Scaffolds were assayed for cell viability
and proliferation as well as glycosaminoglycan (GAG) and hydroxyproline concentration.
Bioreactor scaffolds showed a 700% and 75% increase in DNA and hydroxyproline
concentration respectively as well as a significant decrease in GAG concentration over
the control scaffolds. Surprisingly, little differences were seen between stretched and
unstretched portions of the scaffolds likely due to the conditioned media effect.
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CHAPTER 1
INTRODUCTION
In 2004, musculoskeletal injuries accounted for 60% of all traumatic injuries in
the United States [1]. The tendon-bone interface represents one of the most vulnerable
locations of the musculoskeletal system and accounts for 38% of all musculoskeletal
injuries; almost twice as many as bone fractures [1].
Tendon injuries are graded based on severity – grade 1, 2, and 3 [2]. Grade 1
injuries consist of an overstretching of the tendon with some interstitial tearing; grade 2
injuries include partial tearing of the tendon; grade 3 injuries are severe tears to complete
separation of the tendon. Typically grade 3 injuries are the only ones to ever require any
surgical intervention. Healing times vary depending on the severity of the injury, but full
recovery of serious musculoskeletal injuries is expected no sooner than 6 months after
repair – even with the best recovery and physical therapy [3]. Healing takes many
months for these injuries due to the very low vasculature found in the bone-tendon
interface as a result of the calcified transition zones [4].
1.1. Tendon Organization/ Function
Tendon is the primary mechanism of force transduction from the muscles to the
bones in the human body [5]. Every muscle has a tendon attached at every origin and
insertion to allow for solid fixture onto the bone. The largest and most familiar tendon is
the Achilles tendon that attaches the muscles in the calf to the calcaneus in the heel.
Healthy tendon is comprised of dense regular connective tissue [5]. Fig. 1 shows a
photomicrograph of a tendon magnified 500 times. A tendon consists of many collagen
fibrils bundled together to form larger bundles that eventually result in a single tendon.
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Fig. 2 schematically shows the multi-level components of a typical tendon. Due to the
alignment of the collagen fibrils, tendon is primarily uniaxial and resists tensile
stretching, as its prime function is direct transmission of force from muscle to bone. To
transmit muscle forces to bone effectively, tendons are well anchored to bone. Because
bone is a more rigid material, there is a gradual transition between the tendon and the
bone. This transition is divided into four zones. Zone 1 is collagenous tendon; zone 2 is
uncalcified fibrocartilage; zone 3 is calcified fibrocartilage; zone 4 is calcified bone (Fig.
2) [4].

Figure 1: Photomicrograph of healthy tendon (500x). Depicts collagen fibers (translucent white) and
fibroblasts (dark purple) [5]
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Figure 2: Microscopic structure of tendon (left) and the bone-tendon enthesis (right) [6,7]

Healthy tendon is 65-70% water; but, when dehydrated, 70% of its weight is type
I collagen, 2% elastin, and 2-5% glycoproteins and proteoglycans. The remainder is
tenocyte fibroblastic cells [7]. Glycosaminoglycans (GAGs) are a component of the
proteoglycans found in tendon. Commonly found GAGs in tendon, such as decorin,
Chondroitin-sulfate B, and Chondroitin-sulfate C, are responsible for the alignment and
organization of the collagen fibrils [8]. During healing and regrowth, there are three
stages: the first 72 hours are spent clearing the site of debris; days 5 through 28 are spent
forming disorganized collagen; and after 28 days, the collagen is remodeled and
realigned [9]. Therefore, it is expected that there will be a large increase in cell number
during the stage 1 and the beginning of stage 2, a large increase in collagen during stage 2
plateauing towards the end of that stage, and an increase in GAGs beginning around days
14-18 [9].
A damaged tendon that is left unrepaired will lose most, if not all, of its ability to
transduce force from the muscle to the bone. In a study performed by Mikolyzk et al,
they investigated the histology of injured, steroid treated, and injured with steroid
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treatment tendon in a rat model [10]. Fig. 3 shows the histological findings from their
experiments. The differences between the injured tendon and the healthy (control)
tendon are apparent. The tendon’s elongated shape becomes much more compact as you
see a much denser cluster of nuclei in the one week injury slide. After five weeks of
healing, the collagen and fibroblast cells begin to have their elongated shape again.
There tends to be a greater density of fibroblast nuclei at the injury site due to the body’s
natural reaction to strengthen the injury site.

Figure 3: Histology of infraspinatus tendon in rat model performed by Mikolyzk et al. [10]
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1.2. Current Treatment
When surgery is required, minor surgeries involve suturing the tendon together
with 4-0 and 6-0 polypropylene monofilaments using a curved stainless steel needle and
allowing it to heal [11, 12]. Sutures are satisfactory for minor tendon repair such as
carpal flexor and extensor tendons, but are not satisfactory for major tendons such as the
Achilles tendon or quadriceps tendon due to the large loads being transmitted by the
larger muscle groups. Sutured tendons are able to withstand a tensile stress up to 0.6
MPa, which is far exceeded by the stresses experienced in the larger tendons [12].
Another greatly used repair technique involves using a bone tunnel to reattach damaged
tendon [13-16]. Bone tunnels use bone plugs attached to tendon or tendon pulled through
the tunnel and clamped to prevent pull-through [15]. Unfortunately, these methods are
still far from perfect. Flexor tendon repair surgeries and Achilles tendon repair surgeries
have been reported to have failure rates as high as 17% and 20% respectively [3,9]. As a
result, major surgeries and recent experimental techniques now use tissue engineering to
create scaffolds that aid in tendon repair [17-20]. Tissue engineering offers the potential
for faster recovery and improved tendon repair over standard suturing. Results from
tissue engineering studies look very promising, sparking a significant interest into the
field of tissue engineering.
1.3. Tissue Engineering
One of the overall goals of tissue engineering is to use cells, materials, and
biological substances to improve and repair biological function. This broad field spans
from reconstructing heart valves to culturing new skin for burns to growing entire organs
[21-22]. A specific, ongoing research focus in tissue engineering is repair and re-

5

attachment of the tendon at the bone-tendon enthesis [23-24]. To accomplish this reattachment of the tendon, modified biomaterials are needed. Neo-tissue requires cells
from which to grow, a scaffold or substrate to adhere to, and a medium to feed it [19].
Tendon is primarily comprised of tenocytes derived from fibroblasts and an extracellular
matrix that is predominantly collagen [5].
Early attempts at implantable scaffold devices were similar to what was used by
Joshi et al [23]. They were successful in growing fibroblasts on a Tecoflex® (medicalgrade aliphatic polyether polyurethane) scaffold and improving the elastic modulus of the
resulting hybrid. Improving the material properties of the implanted substrates is critical
to alleviate stress on the repairing tendon so it is not reinjured. One must be careful
though to avoid stress shielding that can actually hinder the effectiveness of the scaffold
[23].
Other considerations taken were making scaffolds more biomimetic to improve
tissue ingrowth and bond strength. Garvin et al. created bioartificial tendon that was
from cultured tenocytes in a collagenous matrix to improve the growth environment on
the flexible silicone rubber membrane [24]. The resulting tendon, while lacking in
mechanical strength as compared to healthy tendon, improved the morphology and
histology as evidenced by the genetic expression of collagen I, III, and XII, decorin, betaactin, and tenascin. Collagen I, II, and XII are common collagen types found in tendon;
decorin is a proteoglycan necessary for ECM organization; beta-actin is a type of actin
useful for cell stability and motility; tenascin is a common glycoprotein found in
connective tissue – especially tendon [24]. The presence of these matrix components,

6

such as collagen types I and II as well as decorin, is promising, as this experimental
method has produced genetic expression for vital components to proper tendon function.
Because a second surgery to remove non-permanent fixtures would not be needed,
engineers have been attempting to grow cells and tissues on degradable and nondegradable fabric scaffolds such as polyethylene terephthalate (PET), polypropylene,
polyglycolic acid (PGA), and polylactic acid (PLA) [24-25]. As a result, recently, Deng
et al. has experimented with growing human neo-tendon on a PGA scaffold [26]. Using a
device to impart constant strain, they were able to culture human neo-tendon using
human dermal fibroblasts. The resulting tissue was indistinguishable from the human
tenocytes cultured from the same source. This achievement has allowed other
researchers to use fibroblasts for tendon culture as opposed to tenocytes – fibroblasts
being less differentiated and therefore more versatile [26].
1.3.1. Mechanical Stimulation
As evident from the study by Deng et al., mechanical stimulation was essential for
creating healthy neo-tendon [26]. Early studies did not subject cells to mechanical
forces, which may have limited organization/function of the engineered constructs. To
simulate the mechanical factors in tendon development and organization, investigators
have begun applying mechanical strain to engineered tendon constructs [27-28].
One of the most widely used bioreactors is the Flexcell Strain Unit that imposes a
vacuum on a thin silicone elastomer membrane resulting in a strain on the cells adhered
to the membrane [27]. Unfortunately, it is a very basic system that does not allow for
segregated culture. Another very popular bioreactor used is the Bose Electroforce 3200
used by Butler et al., which, like the Flexcell system, does not allow for segregated
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culture [29]. Because the bone-tendon interface contains many cell types, such as
fibroblasts, osteoblasts and chondroblasts, and a variety of stress and strain magnitudes,
many researchers have designed their own bioreactors to fit the desired stimuli for their
engineered tissues [23, 27-28, 30-32]. For example, Titze et al. designed a system to
vibrate fibroblasts approximately 1mm between 20 and 200 Hz, which is the type of
stimulation experienced in laryngeal tissue during speech [30]. This system produced
tissue containing elevated amounts of fibronectin, MMP-1, HA Synthase 2, CD 44,
fibromodulin, and decorin; all of which are essential to vital laryngeal tissue. In contrast,
Riboh et al. used entirely different mechanical conditions (4–8% strain at 0.1–1.0 Hz) to
engineer flexor tendon-like tissue [27]. By applying intermittent cyclic strain, they saw
increased cell proliferation over no strain and constant strain. Intermittent strain also
increased total collagen I production, collagen I being the most prevalent collagen type in
tendon [27]. Similar to Riboh et al., Saber et al. cultured flexor tendon using a bioreactor
system with great success [33]. They applied a 1.25N load at 1 cycle/min for one hour
alternating load and rest. Results of their study also confirmed better cell and collagen
alignment. While these groups demonstrated great advances in neo-tendon construct
engineering by growing organized tendon tissue in vitro, the bone-tendon interface is not
addressed. In order for the engineered tissue to function properly, the tendon will need
quality integration into bone.
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1.3.2. Co-culture
In the case of injuries to the attachment site of a tendon to bone, such as tearing
the tendon from the bone, two tissues are primarily involved – tendon and bone (as well
as their associate cellular and matrix components). As a result, researchers have been
looking into co-culture models using fibroblasts, osteoblasts, and non-living biologics.
Wang et al. studied their recreation of the fibrocartilagenous region between the ACL and
bone using fibroblasts and osteoblasts [34]. The two cell types were cultured on one
substrate with an agarose barrier and after a week, were allowed to migrate into coculture. The group studied the effects of this interaction and what effect various media
additions, specifically ascorbic acid and beta-glycerophosphate (β-GP) would have on the
cells. The co-culture yielded an increase in bone related alkaline phosphatase (ALP)
activity and promisingly, an up-regulation of cartilage oligomeric matrix protein
(COMP). Increased ALP activity signifies osteoblast activity and since the tendon-bone
interface is comprised of zones of fibrocartilage, an up-regulation of COMP shows signs
that a more effective attachment could be achieved. However, this study used an
unsegregated co-culture with uncontrolled dispersion of cell types. Because the bonetendon interface is comprised of 4 distinguishable zones, better segregation is desired [4].
1.3.3. Pre-conditioning
Pre-conditioning tissues on scaffolds significantly improves the performance of
the engineered scaffolds [21,27,35]. Riboh et al. conditioned flexor tendons using
constant and intermittent cyclic strain [26]. They were able to control collagen type 1
production and cell proliferation [27]. This phenomenon is also true for other tissues as
well. Moon et al. demonstrated this pre-conditioning effect using muscle cells that, like
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tendon, are very directionally dependent [35]. By cyclically straining the scaffolds
during culture, the actin and myosin elongated and aligned in a parallel fashion in the
direction of the strain as opposed to being balled and scattered. This idea of
preconditioning was also used by Syedain et al. to engineer heart valves [21]. Due to
conditioning their tissue engineered heart valves possessed an elastic modulus very
similar to that of native cardiac tissue.
1.3.4. Dynamic Media
In traditional cell culture, cells are grown in flasks with a static medium. The
medium is allowed to sit until the nutrients are used, it is discarded, and new medium
replaced. Bioreactors, specifically perfusion bioreactors, allow the user to continuously
perfuse fresh medium through the system. It has been shown that static culture
significantly limits cell viability and matrix production in long-term cell studies and
cultures [36]. Using a perfusion system bioreactor may alleviate the problems associated
with this poor diffusion of medium. It has also been shown that increased fluid flow over
certain cell types, such as osteoblasts and chondroblasts, increases extracellular matrix
production through fluid shear [36-37]. Extracellular matrix is largely a strengthening
agent of the tissue, so this results in a stronger scaffold [36-37]. To this point, several
groups have studied the effects of mechanical stimulation, single culture models, coculture models, static medium, and dynamic medium on cells. However, there are no
studies on extensive combinations of these parameters such as co-culture in dynamic
medium with mechanical stimulation. To be able to create a healthier, viable bonetendon engineered construct, these conditions and improvements must be combined to
create improved, novel designs.
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1.4. Bioreactor Design
Our study goal is to combine these bioreactor/scaffold improvements and
modifications into one bioreactor design. From our literature review, no current
bioreactor design allows the user to cyclically strain a portion of the scaffold while
maintaining no strain on another portion. The bioreactor design of this study aims to coculture two different cell types with spatially selective strain. To do this, design ideas
were reviewed from other published bioreactors designed specifically for muscle and
tendon tissue and those using linear strain applicators [29,35,38]. Initially, this bioreactor
will aid in preconditioning multiple spatially selective, co-cultured, degradable scaffolds.
Each scaffold is engineered to imitate the two anchoring areas of the bone-tendon
interface – bone and tendon. For the tendon-anchoring end, fibroblasts may be cultured
on one half of each scaffold and exposed to cyclic strain while on the other half of the
scaffold, i.e. the bone anchoring end, osteoblasts may be cultured in the absence of strain.
This strategy is expected to enable the collagen and other matrix proteins in the
fibroblasts/tendon end to align and grow on the scaffold due to the applied strain while
the osteoblasts are shielded from the strain [27]. It has been shown that osteoblasts
exposed to relatively large cyclic strain tend display fibrocartilagenous tendencies and
create type II collagen especially in the presence of fibroblasts [34]. This design will also
include a perfusion system to provide continuously flowing medium to the bioreactor
chamber.
In addition, this bioreactor design will be able to accommodate a large number of
testing parameters: strain, strain frequency, type of scaffold, length of scaffold, ratio of
scaffold strained, and flow rate of perfused medium via computer control of the linear
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mechanical actuator, clamp and pump system. These variables may be easily changeable
at the start of any study by inputting changes in the computer program, removing selected
clamps within bioreactor and/or adjusting pump controls. As was encountered by
Syedain et al, very few bioreactor systems are able to control or record the strain
transmitted to the scaffolds; but due to our ability to use position feedback, our design
will be able to specify the stretch and record it.
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CHAPTER 2
AIMS
The goal of this project is to design and validate a cyclic strain bioreactor system
capable of stretching multiple scaffolds while isolating a portion of each scaffold from
the stretching. This bioreactor system will be important in the field of tissue engineering
by providing a resource to investigate tendon and ligament tissue regeneration and wound
healing leading to improved function and faster healing times for major musculoskeletal
injuries. As the design lends itself to co-culture, it may also provide a platform for
exploring the material-mechanical effects on tendon and bone cell differentiation,
proliferation, and extracellular matrix production and organization to better understand
the healing and repair/regeneration process at the bone-tendon enthesis. The aims of this
project are to:
1. Design and construct a cyclic strain bioreactor system capable of stretching multiple
scaffolds simultaneously while isolating a specified portion of each scaffold to receive no
stretch.
2. Measure the mechanical strain experienced on the scaffolds.
3. Evaluate the cellular response to mechanical stimulation via the bioreactor system
using NIH-3T3 fibroblasts.
4. Characterize the matrix response to mechanical stimulation via the bioreactor system
using NIH-3T3 fibroblasts.
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CHAPTER 3
MANUSCTRIPT
Design and Validation of a Cyclic Strain Bioreactor to Condition Spatially-Selective
Scaffolds in Dual Strain Regimes
Annals of Biomedical Engineering

ABSTRACT
The objective of this study was to design and validate a unique bioreactor design
for applying spatially selective, linear, cyclic strain to degradable and non-degradable
polymeric fabric scaffolds. This system uses a novel three-clamp design to apply cyclic
strain via a computer controlled linear actuator to a specified zone of a scaffold while
isolating the remainder of the scaffold from strain. Image analysis of polyethylene
terephthalate (PET) woven scaffolds subjected to a 3% mechanical stretch demonstrated
that the stretched portion of the scaffold experienced 2.97±0.13% strain (mean ± standard
deviation) while the unstretched portion experienced 0.02±0.18% strain. NIH-3T3
fibroblast cells were cultured on the PET scaffolds and half of each scaffold was
stretched 5% at 0.5 Hz for one hour per day for 14 days in the bioreactor. Cells were
checked for viability and proliferation at the end of the 14 day period and levels of
glycosaminoglycan (GAG) and collagen (hydroxyproline) were measured as indicators of
extracellular matrix production. Scaffolds in the bioreactor showed a seven-fold increase
in cell number over scaffolds cultured statically in tissue culture plastic petri dishes
(control). Bioreactor scaffolds showed a lower concentration of GAG deposition per cell
as compared to the control scaffolds largely due to the great increase in cell number. A
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75% increase in hydroxyproline concentration per cell was seen in the bioreactor
stretched scaffolds as compared to the control scaffolds. Surprisingly, little differences
were experienced between the stretched and unstretched portions of the scaffolds for this
study. This is largely attributed to the conditioned media effect. Results indicate that the
bioreactor system is capable of applying spatially-selective, linear, cyclic strain to cells
growing on polymeric fabric scaffolds and evaluating the cellular and matrix responses to
the applied strains.
Keywords – Bioreactor, Cyclic strain, Fibroblast, Tendon, Cell-culture

INTRODUCTION
Tissue engineering strategies have shown promise in aiding the repair of damaged
tendons.4-5,16,22 Studies have shown that the addition of cells on scaffold-based constructs
has greatly improved the constructs’ elastic moduli, tensile strength, and biological
response of native tissue as compared to synthetic/non-cell materials.6,8,10
Because tendons are mechanically responsive, studies have examined the effects
of mechanical stretch on engineered tendon tissues by a variety of mechanisms such as
linear actuators, perfusion chambers, electric motors, vacuum systems, and audio
speakers.3,6,14,23 In general, cell-scaffold constructs subjected to mechanical strain
showed increased stiffness and tensile strength over statically cultured constructs.3,14 The
addition of cyclic strain showed increased collagen type I production as well as
cytoskeletal rearrangement.3,14 Intermittent cyclic strain caused increased cell
proliferation while constant cyclic strain led to cell-mediated apoptosis.14
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Because of the complexity of the bone-tendon enthesis, one challenge that still
remains is the integration of engineered tendon into bone because these constructs lack
the normal transition zones in the bone-tendon enthesis.3,6,14,23 To address this problem,
researchers have co-cultured tenocytes or fibroblasts, and osteoblasts.1,11,20-21 Wang et al.
showed the ability to create an unstrained construct divided into three zones: primarily
fibroblastic, primarily osteoblastic, and a third zone that was a mix of fibroblasts and
osteoblasts.21
While bone is also a mechanically responsive tissue, if subjected to the same large
strains as tendon, it tends to form fibrocartilagenous tissue instead of bone.21 In order to
engineer tendon that mimics the bone-tendon enthesis, it would be ideal to be able to use
large mechanical stretch to stimulate tendon formation on one end of the scaffold while
minimizing tensile stretch on the other end to favor bone formation. Therefore, the study
aim was to design bioreactor able to support the engineering of scaffolds with
differentiated osseous and fibroblastic attachment zones.
This design was initially validated using fibroblast culture to investigate the
difference in cellular and matrix response to the different strain zones on the scaffold.
Responses were characterized by cell proliferation, glycosaminoglycan (GAG)
deposition, and collagen deposition onto the scaffold. The presence of these elements of
tendon has been shown to indicate healthy tendon tissue.21
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MATERIALS AND METHODS
Bioreactor System
The bioreactor system design was modified from a commercially available
bioreactor (BOSE Electroforce 3200) to provide differential stretch to portions of the
scaffolds. The overall system is composed of two major sections: a baseplate (composed
of 6061 aluminum alloy) and a removable polycarbonate chamber (Fig. 1). The chamber
is removable from the base and replaced with another chamber so concurrent tests may be
performed. This system uses a linear actuator to apply linear, uniaxial strain to a group of
parallel scaffolds fixed inside the chamber. The overall dimensions of the system are 7in.
x 17.5in. which allows it to fit inside of a standard cell incubator.
The bioreactor chamber is constructed of ¼” plates of polycarbonate fitted
together using 316L stainless steel socket head cap screws and then sealed with silicone
(100% Clear Aquarium Silicone, Marineland) along both the outside and inside edges to
make the chamber watertight. The clamps, screws, and actuator inside the chamber are
also made of 316L stainless steel.
The novel 3-clamp design involves three clamps: an actuating, fixed, and
adjustable clamp (Fig. 2). This design allows scaffolds of different materials and sizes, as
well as portions of scaffold subjected to mechanical perturbation. The actuating clamp is
connected to the linear actuator and is used to mechanically stretch the scaffold by
pulling on one end of the scaffold. The fixed clamp is used to hold the opposite end of the
scaffold in a fixed position. The adjustable clamp may be used to create two distinct
zones of mechanical stretch (a non-stretched zone (A) and a stretched zone (B)) by
creating a fixed section in the central region of the scaffold. The adjustable clamp may
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be moved to other positions designated by the extra holes visible in Fig. 2. This
adjustability allows for varying scaffold lengths and larger/smaller percentages of the
scaffold to be stretched. In addition, different cell types may be seeded in zones A and B
allowing for spatially segregated co-cultures as well as intermixed co-cultures. After
stretching begins, the fixed clamp and actuating clamp are intended to remain in place;
but, the adjustable clamp may be removed for non-segregated co-culture when two cell
types are used.
Medium is pumped with a Masterflex pump through the bioreactor chamber at 6070 mL/min through an inlet to the side of the scaffolds and an outlet at the opposite
corner. Gas permeable tubing (Cole-Parmer, Vernon Hills, IL, USA) allows for CO2 and
O2 gas exchange as the medium circulates. The bioreactor chamber and tubing are
sterilized using steam autoclave at 121°C and 15 psi for 20 minutes.
A LabVIEW program (v. 8.0 National Instruments, Austin, TX) was created to
control the 2” stroke 150lb force linear actuator, with potentiometer feedback (FA-PO150-12-2, Firgelli Automations, Surrey, BC, Canada), that is used to mechanically stretch
the scaffolds. The program is used to control frequency, magnitude, and duration of
mechanical stretch to meet experimental conditions.

Mechanical Characterization
To characterize the mechanical performance of the bioreactor, 4 Polyethylene
Terephthalate (PET) (Biomedical Structures, Warwick, RI, USA) fabric samples (10mm
x 80mm) were clamped in the bioreactor and marked with small graphite dots (Fig. 3).
The LabVIEW program was set up to apply a 3% stretch chosen as an expected applied
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stretch to be used with this bioreactor. 3% is also large enough to measure a noticeable
strain but also small enough that the accuracy/repeatability of the system can be tested.
The LabVIEW program was run through 24 strain cycles and pictures taken at each step
in the cycle. Observed strain was recorded from the measurements taken.

Cellular Characterization
Six large PET scaffolds (8mm x 87.5mm) and seven small PET scaffolds (8mm x
25mm) were cut from a large spool and their cut ends lightly melted by touching them to
a heated steel bar to prevent fraying. Scaffolds were sterilized by sonicating in each of
the following solutions for 30 minutes: 1% Ivory dish soap solution, deionized (DI)
water, and a second time in DI water. Samples were placed in 70% ethanol for 30
minutes and finally sterilized by exposure to UV light for at least 30 minutes per side.
After sterilization, but before seeding, scaffolds were rinsed with sterile 1x PBS
and then pre-exposed to culture medium, Dulbecco’s Modified Eagle Medium High
Glucose (HyQ® DMEM, HyClone, Logan, UT) supplemented with 10% fetal bovine
serum (FBS, Cat. No. 30-2020, ATCC) and 1% antibiotic/antimycotic (AB/AM, 100
U/mL penicillin, 100μg/mL streptomycin, 0.25 μg/mL amphotericin B) by soaking the
scaffolds in sterile 50mL centrifuge tubes for at least 30 minutes to allow the medium to
penetrate the scaffold and proteins to start attaching.
NIH-3T3 mouse fibroblast cells were cultured in DMEM-High Glucose +
10%FBS + 1% AB/AM at 37°C with 5% CO2. Cells were pipetted at a density of 1x105
cells/cm2 in four spots along the length of six large (8mm x 87.5mm) and seven small
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(8mm x 25mm) scaffolds, and kept in three 3.5in. diameter TCP petri dishes and seven
individual 1.5in. TCP petri dishes respectively overnight to allow attachment.
Two groups were tested in this experiment: a control group (static culture) and an
experimental group (bioreactor). The experimental group was divided into two
subgroups. Subgroup 1 of the experimental group was cultured in the bioreactor, but
experienced no stretch. Subgroup 2 of the experimental group was also cultured in the
bioreactor, but was subjected to 5% mechanical stretch at 0.5Hz for one hour per day for
14 consecutive days. Table 1 lists the characteristics for each experimental group.
After seeding and incubation overnight, scaffolds were divided into their
respective groups. On day 1, the six scaffolds were clamped in the bioreactor and 250mL
of DMEM-High Glucose medium further supplemented with 1mM betaglycerophosphate (β-GP) was added. The six smaller scaffolds, sized such to represent
the same surface area as the other groups, remained in their petri dishes and 2mL of
medium was added to each. The remaining small scaffold selected for determining initial
cell attachment was removed, rinsed with sterile 1x PBS, and then stored at -20°C.
Stretching on day 1 began 2 hours after clamping to allow any cells that may have
become dislodged or perturbed to reattach to the scaffold.
Over the 14-day period, the medium was supplemented with 10μg/mL of ascorbic
acid every 3 days as ascorbic acid has been proven to improve type I collagen deposition
in fibroblast cells.9 The medium of the control scaffolds was changed every 3 days.
However, due to the much greater volume in the medium reservoir of the bioreactor, the
medium of the experimental group scaffolds was changed every 6 days.
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Experimental parameters were chosen based on their use in the literature. The
stretching protocol is similar to that used by other groups such as Garvin et al. and Riboh
et al.8,14 Daily intermittent straining was chosen as it has been shown that intermittent
straining increases collagen I production and cell proliferation.14 14 days is also a
common time for tendon tissue engineering bioreactors.14,23 Concentrations of β-GP and
ascorbic acid were chosen as the having the most positive effect on cell proliferation and
collagen I production in tests performed by Wang et al.21 Mechanical stretching of the
scaffolds took place in a cell incubator (37°C, 5% CO2, 95% humidity).
Scaffolds were removed from the bioreactor and petri dishes 2 hours following
the final stretch of day 14. All scaffolds were cut into three approximately equal sized
sections (8mm x 8mm) and their surface area recorded (Fig. 4). By sectioning the
scaffolds, we are able to determine if the matrix on the scaffolds is uniform over the
whole scaffold as well as across all of the scaffolds. If any non-uniformity is noted, it
may be possible to determine if effects are caused by proximity of the clamps (section 1,
2, or 3) or by position of the scaffold (scaffold A-F).
To remove the cells for analysis, each scaffold section was rinsed with sterile 1x
PBS and placed into labeled Erlenmeyer tubes with 1mL of 50μg/mL Proteinase K (ProK, Promega Corporation, Madison, WI) solution (50μg/mL Pro-K, 50mM Tris-HCL,
50mM CaCl2 buffer, pH 7.5) and placed overnight in an oven at 60°C. The following
day, 50μL of proteinase inhibitor (phenylmethylsulfonyl fluoride (PMSF), MP
Biomedicals, Solon, OH, USA) was added and a sonic dismembraner (Fisher Scientific
Sonic Dismembraner 550, Fisher Scientific, Pittsburg, PA, USA, Setting 2) was used to
disrupt any remaining cells and matrix. This cell lysate was used to estimate cell number.
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One scaffold was not digested in the Pro-K solution and used instead to view cells on
scaffold using a Live/Dead® assay (Invitrogen, Grand Island, NY, USA). From the
assay protocol, viable cells will fluoresce green and dead cells will fluoresce red.
The PicoGreen assay (Invitrogen, Grand Island, NY, USA) was to measure DNA
as an indicator of the number of cells on scaffolds. For the assay, the 100 μL of
PicoGreen reagent was added to 20μL of the cell/matrix lysate in 80 μL of tris-HCLEDTA buffer in a 96 well opaque microplate. The plates were read at 485 nm excitation
and 528 nm emission using a spectrophotometer. A linear standard curve (2 μg/mL serial
dilution) was prepared from a DNA standard (100μg/mL). DNA was normalized to
surface area, ngDNA/mm2, for each scaffold section.
Glycosaminoglycans are polysaccharides that are a major component of tendon
extracellular matrix.13 To quantify the concentration of GAG, the Alcian blue assay was
used. 250μL of each prepared sample (cell lysate with Alcian blue) and 100μL of each
prepared chondroitin sulfate standard (400 μg/mL serial dilution) was transferred to a 96well plate and the absorbance read at 620nm. Sample concentrations of GAG were then
normalized by DNA to ngGAG/ngDNA.
Elaboration of collagen by cells is an indicator of cellular matrix production. The
hydroxyproline assay was used to measure collagen. According to Stegemann and Salter,
hydroxyproline can be linearly translated to collagen by multiplying by a factor of 7.46,
i.e. 1 μg/mL hydroxyproline is equal to 7.46 μg/mL collagen.19 First, 25 μL of prepared
hydroxyproline (HP) standard (Sigma-Aldrich, St. Louis, MO, USA) (100 μg/mL serial
dilution) and 25μL of 16x concentrated prepared sample were added to each well of a 96well plate. Prepared chloramine-T solution (112.5μL) was added and incubated at room
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temp for 20 min. Immediately following, 125μL of prepared Ehrlich’s reagent were
added to each well, incubated for 20 minutes at 65°C in an oven, and the absorbance read
at 550 nm. Sample concentrations of collagen were then normalized by DNA to
ngHP/ngDNA.

Statistical Analysis
Means among section position and scaffold location were calculated and a twofactor ANOVAs performed; one factor was the individual scaffolds (A-E) and the other
factor was scaffold section (1-3) to one another. This was done for each of the three
groups. Differences were considered significant at p<0.05. Differences were determined
using Tukey’s Post-hoc testing.
When no significant differences were determined, results were pooled and oneway ANOVA was performed to test differences between test groups (n=5) for the GAG
and hydroxyproline data. Differences were determined using Tukey’s Post hoc testing
and were considered significant at p<0.05.

RESULTS
Mechanical Characterization
Fig. 5 shows the LabVIEW waveform for the actuator to apply mechanical stretch
to test scaffolds in the bioreactor. The large spikes at the end of each plateau are a
phenomenon caused by the sampling and recording and are not representative of
stretched applied to the scaffolds.

23

Results of the video analysis of the reference dots on the 4 PET scaffolds
subjected to the programmed 3% stretch at 0.1 Hz for 24 cycles is shown in Fig. 6. The
figure shows the mechanical stretch of the stretched portion and the non-stretched portion
of the scaffolds. The average strain experienced by the stretched scaffolds was
2.97±0.13%. The average strain experienced by the unstretched scaffolds was
0.02±0.18%.
From the camera resolution limitations, visual representation of 0% strain was
very difficult to obtain. However, the resolution of the pictures taken was 1 pixel~0.5%
strain, so values less than 0.5% were assumed to be 0%. Because the LabVIEW program
was designed as an open loop control system, errors from one stretch cycle do not
translate to the following stretch cycle as evidenced by the positive and negative
differences of cycles 10-15.

Cellular Characterization
Images of the experimental and control scaffolds stained with the Live/Dead
reagent at the end of the 14-day culture period are shown in Fig. 7. Images were taken of
each of the three assayed sections in each group at magnifications of 10x and 20x. The
images showed that there were many live/viable cells on all scaffold groups and scaffold
sections. The cells uniformly covered the majority of the surface area of the scaffolds
and cells were observed growing on fabric fibers within the scaffold.
Using measured cell DNA data, two-way ANOVA was performed on test samples
to determine if there were any effects based on proximity of cells on scaffolds to the
clamps or on position of scaffolds in the bioreactor. No statistical differences were found
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between zones or proximity of cells to clamps with in each experimental group (p>0.18)
nor were differences detected for position of scaffolds in bioreactor for each experimental
group. Since there were no effects of position on the scaffold or position within the
bioreactor based on DNA data, scaffolds were then treated as a single test unit in
subsequent analyses.
Fig. 8 shows the results of total DNA on scaffolds in each experimental group
after 14 days. One-way ANOVA revealed that the DNA concentration in all groups was
not equal (p<1x10-6). A large increase was found in the DNA concentration of the
bioreactor unstretched group as compared to the control group (p<1x10-6) as well as the
bioreactor stretched group as compared to the control group (p<1x10-6). However, no
difference was found between the DNA concentration of the bioreactor unstretched group
and bioreactor stretched group (p>0.90).

Matrix Characterization
To investigate the effect of mechanical stretch on levels of extracellular matrix,
GAG was measured via the Alcian Blue assay and then normalized to DNA. One-way
ANOVA with post-hoc Tukey tests showed that the amount of GAG per DNA was
statistically lower in the bioreactor as compared to the static culture (p<0.001), but there
was no difference between strained and unstrained sections of scaffolds in the bioreactor
(Fig. 9) (p>0.99).
Hydroxyproline (HYP), like GAG, was normalized to DNA and showed a
difference between experimental groups (Fig. 10) (p<0.01). The bioreactor unstretched
group showed an increase in hydroxyproline per DNA as compared to the control group
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(p<0.05) as did the bioreactor stretched group (p<0.01). The bioreactor unstretched and
stretched groups still showed no significant differences in hydroxyproline deposition
when normalized to DNA (p>0.25).
DISCUSSION
This study presented an enhanced bioreactor design that is able to cyclically strain
preferential zones of multiple, fabric, cell-seeded scaffolds in a controlled in vitro setting.
This system has potential to develop degradable and non-degradable fabric scaffolds with
improved matrix deposition over basic statically cultured scaffolds. Analysis with
photographic video demonstrated that the system is able to deliver accurate and
repeatable cyclic stretch to a designated portion of each scaffold while isolating the
remainder of the scaffold from stretch. In addition, the system may accommodate
numerous variables including, scaffold length, width, and material as well as stretch zone,
magnitude, frequency, and schedule. Furthermore, each bioreactor chamber could
interchange with a second identical bioreactor chamber for concurrent studies using
similar or differing experimental conditions.
Minor variations of less than 10% of the desired strain magnitude were noticed
between stretch cycles, which were attributed mostly to the process of the marking for the
video analysis. The method used to mark the scaffolds for analysis was sufficient for
initial validation purposes, but lacked fine resolution. Many methods were attempted to
mark the scaffolds to measure the distance between marks – graphite providing the most
accurate method. The camera used also had a limited resolution. For more exact values,
a camera or microscope with higher resolution would give decreased error to the
measurements taken. However, the system did prove that it could consistently stretch as
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low as 1% and at least as high as 10% for a 1-inch scaffold (data not shown).
Unfortunately, over a 14 day period, there was some laxity noticed in the scaffolds likely
due to viscoelasticity.
Investigating the effect of location within the bioreactor and the proximity to a
clamp revealed that the scaffolds were statistically equivalent and could be treated as
uniform. Live/Dead staining demonstrated that cells remained viable on the scaffolds in
both the bioreactor and in control cultures over the 14-day experimental time frame.
Non-viable cells were also evident on the scaffolds. The viable cells on the scaffolds in
the bioreactor are still at a much greater density than the viable cells on the control
scaffolds, despite the increase in non-viable cells. Also, the cells in the bioreactor,
especially the stretched cells, began to show alignment along the scaffold fibers. Riboh
et al. also noticed this phenomenon with cytoskeletal and nuclear rearrangement due to
uniaxial cyclic stress.14
Quantitative analysis of the DNA concentration on the scaffolds supported our
qualitative findings. Intermittent cyclic strain increased DNA concentration seven times
on the scaffolds in the bioreactor as compared to the control scaffolds. This agreed with
other studies investigating the effects of varying schedules of intermittent cyclic strain
over static culture.2,14 Application of mechanical strain to these cells activates the
mitogen-activated protein kinase pathway as well as mechanosensitive calcium channels
initiating the proliferative response.14 However, our findings did not agree with Screen et
al. who did not see any change in cell proliferation on a cyclically strained tendon.17
However, their studies were only performed for 24 hours and used a grafted tendon as
their scaffold material.17
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Initially, it was surprising that there were no differences detected in DNA and
elaboration of extracellular matrix components between strained and non-strained
scaffold sections since cyclic strain has been shown to have such a large effect over the
static control petri dish scaffolds. It was expected that the proliferation increase of the
strained scaffolds over the unstrained scaffolds would be much greater than the
unstrained scaffolds over the control scaffolds. We attribute this to a concept known as
conditioned media since the media was recycled by the pump system. Multiple groups
have shown that instead of directly or mechanically stimulating cells, replacing the
culture medium with a conditioned culture medium can induce a response from the cells
based on chemical signals present in the medium.7,12,18 For example, by using medium
that was used to stretch osteoblast cells, Soma et al. was able to induce osteoclast
proliferation by using the discarded medium as a conditioned medium. It contained all of
the cellular signals telling osteoblasts to proliferate, which in turn caused the osteoclast
cells to initiate the homeostatic tendencies by proliferating.18 This same phenomenon
may be occurring inside the bioreactor as the unstretched scaffolds shared medium with
the strained scaffolds. The cells on the unstrained scaffolds are receiving the same
cellular signals as the cells on the strained scaffolds, but not the mechanical stimulation.
The tendon reconstruction schedule, proposed by Rust et al., shows that cell
proliferation peaks around day 5, followed by a large increase in unorganized collagen
deposition (days 5 – 28).15 The collagen deposition overlaps slightly with an increase in
GAG deposition beginning around day 21 and increasing through day 28 and beyond.15
Our analysis occurred in the middle of the collagen growth peak based on Rust et
al., which would ideally show us if cyclic strain increased the concentration of collagen
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as well as the rate of production. We found a 44% increase in hydroxyproline
concentration on the unstrained scaffolds in the bioreactor as well as a 75% increase in
hydroxyproline concentration on the strained scaffolds in the bioreactor as compared to
the control scaffolds. A similar trend has been previously reported by Riboh et al. as
intermittent cyclic strain was shown to increase type I collagen production using
fibroblastic cells.14 The strained scaffolds cultured by Screen et al showed no significant
increase in hydroxyproline concentration over the unstrained control scaffolds.17
Interestingly though, there was a large increase in hydroxyproline concentration present
in the medium of the strained scaffolds over the unstrained scaffolds.17
Analysis of GAG concentration on the scaffolds in the bioreactor shows an
interesting trend. Overall, there was a greater mass of GAG on the bioreactor scaffolds
than on the control scaffolds, but the static control petri dish scaffolds deposited four
times more GAG per cell on the scaffolds as the bioreactor scaffolds. It would appear
that cyclic strain had a negative effect on GAG deposition; but the trend is misleading
because of the drastically large increase in DNA concentration on the bioreactor
scaffolds. At day 14, when these scaffolds were assayed, the large increase in GAG
deposition proposed by Rust et al. would not have begun; therefore, it is not surprising to
have a lower concentration of GAG per cell on the bioreactor scaffolds due to the large
increase in bioreactor cell proliferation. Sampling around day 28 may provide a better
investigative time point to analyze the bioreactor’s effect on the elaboration of GAG.
While these results seem surprising, our findings do agree with Screen et al. where they
saw a statistically significant decrease in GAG concentration on their strained scaffolds
as compared to their unstrained scaffolds.17
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A unique bioreactor system was designed, developed, and shown to apply a
known, user-specified, cyclic strain to cells growing on polymeric fabric scaffolds. The
strain environment experienced by the cells was quantified and reproducible. Strain was
able to be isolated from a specified portion of each scaffold while stretching the
remainder. Differences in cellular proliferation, GAG concentration, and hydroxyproline
concentration were measured based on static and dynamic culture conditions experienced
by the cells. The bioreactor system may be used to evaluate the effects of mechanical
stretch on degradable and non-degradable fabric scaffolds.
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TABLES:
Table 1: Experimental group characteristics

Group

Location

Stretch Schedule

Control

TCP Petri Dish

No stretch

Unstretched

Bioreactor

No stretch

Stretched

Bioreactor

5%, 0.5Hz, 1hr daily, 14 days
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FIGURES:
Chamber

Perfusion

Base

Figure 1: Bioreactor chamber in stretching base
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Actuator

Fixed
Clamp
B

Adjustable
Clamp

Actuating
Clamp

A

B

A

Figure 2: Bioreactor chamber three-clamp design. (A) Portion of the scaffold experiencing strain. (B)
Portion of the scaffold that remains under 0% strain conditions.
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Actuating
Clamps

d2

d1
Adjustable
Clamps
d3

d4

Scaffold
s

Schematic 1:
Unstretched

Fixed
Clamp
s

Schematic 2:
Stretched

Figure 3: Two schematics of the strain characterization. Schematic 1 represents the photo of an unstretched
scaffold. Schematic 2 represents a picture of the same scaffold under a specified stretch. Comparing to Fig. 2,
d1 and d2 are markers inside of zone A while d3 and d4 are markers inside of zone B.
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Figure 4: Relative position of each section of scaffold for assays. Position 1, 2, and 3 refer to position on
the scaffold and proximity to clamps. L/D refers to sections of the scaffolds designated for Live/Dead
imaging.
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Figure 5: Sample waveform for controlling actuator to apply mechanical stretch to scaffolds in bioreactor.
Parameters set were 5% stretch at 0.2 Hz.
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Stretch Cycle

Figure 6: Stretch cycles of the PET scaffolds in the bioreactor. Each bar represents the average strain
across all four scaffolds for that stretch cycle. Error bars represent one standard deviation. n=4.
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A

B

C

Figure 7: Live/Dead images of section 2 of each scaffold magnified at 10x. Green represents those cells
that are alive/viable and red represents those cells that are dead/non-viable. A) Static Petri Dish Control;
B) Unstretched; C) Stretched. Arrows signify cells aligning along scaffold fibers.

40

Figure 8: DNA concentration of each experimental group. Data from all three sections of each scaffold
were combined to compare the effect had over the whole scaffold. n=5. Error bars represent one standard
deviation. #Statistically different than control (p<1x10-6).
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Figure 9: GAG deposition normalized to DNA (ngGAG/ngDNA). n=5. *Statistically different than
control (p<0.001).
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Figure 10: Hydroxyproline deposition normalized to DNA (ngHYP/ngDNA). n=5. @Statistically
different than control (p<0.05). $Statistically different than control (p<0.01).
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CHAPTER 4
FUTURE STUDIES
In future studies with this bioreactor system, it is suggested that multiple cell
types be used in co-culture under varying mechanical load conditions. This study used
only fibroblast cells; but, by using different cells such as NIH-3T3 fibroblasts and MC3T3 osteoblasts, it may be possible to investigate how this system affects co-culture. In
addition, it would be interesting to investigate the effects that the bioreactor has on cells
that are not fully differentiated. Aside from altering the cell types used, other scaffold
substrates would be beneficial to test such as a degradable polymer like poly-lactic acid
(PLA) or poly-glycolic acid (PGA) as they are commonly used in tendon reconstruction
surgeries.
For this study, we investigated only one loading scenario – 5% at 5 Hz for one
hour daily. Future studies could be conducted to characterize the effects of varying the
strain magnitude, frequency, and schedule. Also, this study was ended after 14 days. It
would be beneficial to test the bioreactor at other important time points in the tendon
reconstruction schedule such as 5 days for cell proliferation, 21 days for collagen and
GAG, or 28 days for GAG.
A more in depth study of specific extracellular matrix elements would be very
beneficial as well. Our assays tested for the presence of any GAGs as well as all
hydroxyproline. Specific GAGs such as decorin and chondroitin sulfate are very
important in healthy tendon, but serve very different purposes. Assaying for specific
elements would better inform us where improvements have been made in tendon
reconstruction. The same is true for the hydroxyproline – it does not test for specific
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collagen types. Testing for specific collagen types, such as types I and III, would indicate
growth of tendon and bone verses type II which would indicate growth of a more
fibrocartilagenous tissue. This knowledge would allow us to better map our imitation of
the bone-tendon enthesis transition zone. Performing gel permeation chromatography
(GPC) would also allow us to see other matrix elements, such as growth factors, that have
been genetically upregulated, but are otherwise difficult to test.
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CHAPTER 5
CONCLUSIONS
A unique bioreactor system was designed, developed, and shown to apply a
known, user-specified, cyclic strain to cells growing on polymeric fabric scaffolds. The
strain environment experienced by the cells was quantified and reproducible. Strain was
able to be isolated from a specified portion of each scaffold while stretching the
remainder. Differences in cellular proliferation, GAG concentration, and hydroxyproline
concentration were measured based on static and dynamic culture conditions experienced
by the cells. The bioreactor system may be used to evaluate the effects of mechanical
stretch on degradable and non-degradable fabric scaffolds.
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CHAPTER 7
APPENDIX
The mechanical characterization was performed using two different materials:
PET, as shown previously, and polylactic acid (PLA). The data for the PLA scaffolds
was not included since that scaffold material was not used in the cellular and matrix
characterizations. Figure A1 shows the mechanical strain data for the PLA scaffolds
undergoing 5% stretch.
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Figure A1: Stretch cycles of the PET scaffolds in the bioreactor. Each bar represents the
average strain across all four scaffolds for that stretch cycle. Error bars represent one
standard deviation. n=4.
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The Live/Dead assay was performed for all scaffold sections under 10x and 20x
magnification. Only section 2 under 10x magnification was shows previously. Figures
A2, A3, and A4 show the Live/Dead images of the control, unstretched, and stretched
scaffolds respectively. Images on the left (A, C, and E) show 10x magnification and the
images on the right (B, D, and F) show 20x magnification.
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Figure A2: Live/Dead images of the control scaffolds. Green represents those cells that
are alive and red represents those cells that are dead. A) Section 1, 10x. B) Section 1,
20x. C) Section 2, 10x. D) Section 2, 20x. E) Section 3, 10x. F) Section 3, 20x.
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Figure A3: Live/Dead images of the bioreactor unstretched scaffolds. Green represents
those cells that are alive and red represents those cells that are dead. A) Section 1, 10x.
B) Section 1, 20x. C) Section 2, 10x. D) Section 2, 20x. E) Section 3, 10x. F) Section 3,
20x.
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Figure A4: Live/Dead images of the bioreactor stretched scaffolds. Green represents
those cells that are alive and red represents those cells that are dead. A) Section 1, 10x. B)
Section 1, 20x. C) Section 2, 10x. D) Section 2, 20x. E) Section 3, 10x. F) Section 3, 20x.
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